Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q1 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.2 million versus the consensus estimate of $3.38 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.

Earnings